ARCHIVES

Study: CYP2D6 Genotypes Are Unreliable Predictors of Benefit

This article is from The Cancer Letter archive.

Vol. 35 No. 3 | March 30, 2012

Download PDF Visit The Full Archive

Related Articles

Trials Suspended At Oklahoma Over Study Of Cancer Vaccine.

July 14, 2000

NCI Programs: HMO Research Network wins $16 Million Grant for Prevention Studies

July 30, 1999

Shalala Named President, University Of Miami.

November 24, 2000

Hollings Resolution Recognizes 20th Year Of National Cancer Act

May 3, 1991

In Brief: Cancer Act Renewal Nears, Appropriations Bills Lag; Interim Funding Likely For ’83 Fiscal Year

September 24, 1982

SSO Education Group Lists “Major Unmet Needs, Problems”

November 25, 1983